Linden Advisors’s Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 NFYS.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding NFYS.WS
CSD
AA
EAM
SIA
CS
Linden Advisors's NFYS.WS Position: Q3 2024 in Review
Linden Advisors sold out of Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFYS.WS) in Q3 2024, closing a stake of 128,100 shares — an estimated $5.44K sold.
Linden Advisors first reported a position in NFYS.WS in Q1 2022 and held it in 10 quarters. The position peaked at $37K in Q1 2022. 5 funds tracked by Wall St. Rank hold NFYS.WS as of Q3 2024.
- Linden Advisors reported no remaining Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2024 after selling out during the quarter.
- Linden Advisors sold 128,100 Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2024, an estimated $5.44K.
- Linden Advisors first reported a position in Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 10 quarters.
- Linden Advisors's Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $37K in Q1 2022.
- 5 funds tracked by Wall St. Rank held Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2024.
Based on Linden Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.